Carolina Schinke

Also affiliated with University of Arkansas for Medical Sciences

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 17 papers. Top paper: “Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth”.

Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth

Nature Communications(2024)10.1038/s41467-024-44873-4

N/A

0.571DataRank · unranked

44 citations

Yan Cheng, Visanu Wanchai, Wancheng Guo, David Mery, Hongwei Xu +18 more

Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience

Bone(2021)10.1016/j.bone.2021.115876

N/A

0DataRank · unranked

7 citations

Manoj Kumar, Rohan Samant, Rudy Van Hemert, Erming Tian, Shivang Desai +9 more

Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status

Haematologica(2021)10.3324/haematol.2021.278779

N/A

0DataRank · unranked

3 citations

Milan Bimali, Luis F. Carrillo, Archana Sachedina, Daisy Alapat, Md Shadiqul Hoque +14 more

Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e20031

N/A

0DataRank · unranked

3 citations

Sravani Gundarlapalli, Richa Parikh, Mathew Kottarathara, Yetunde Ogunsesan, Shadiqul Hoque +11 more

The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states

Nature Communications(2022)10.1038/s41467-022-32145-y

N/A

0DataRank · unranked

76 citations

Carolina Schinke, Francesco Maura, Michael Bauer, Cody Ashby, Shayu Deshpande +11 more

The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States

Research Square(2022)10.21203/rs.3.rs-1177985/v1

N/A

0DataRank · unranked

0 citations

Leo Rasche, Carolina Schinke, Francesco Maura, Michael Bauer, Cody Ashby +11 more

High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101214

N/A

0DataRank · unranked

17 citations

Fumou Sun, Daisy Alapat, Visanu Wanchai, David E. Mery, Wancheng Guo +24 more

A gene signature can predict risk of MGUS progressing to multiple myeloma

Journal of Hematology & Oncology(2023)10.1186/s13045-023-01472-y

N/A

0DataRank · unranked

14 citations

Yan Cheng, Jun Ying, David E. Mery, Samer Al Hadidi, Visanu Wanchai +16 more

Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns

Blood Cancer Journal(2020)10.1038/s41408-020-0336-z

N/A

0DataRank · unranked

38 citations

Eileen M. Boyle, Cody Ashby, Yan Wang, Valeriy V. Lyzogubov, Christopher P. Wardell +16 more

Editorial: The role of the bone marrow microenvironment in multiple myeloma evolution and therapy

Frontiers in Oncology(2023)10.3389/fonc.2023.1157555

N/A

0DataRank · unranked

3 citations

Niels Weinhold, Jesús Delgado‐Calle, Carolina Schinke

Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages

Blood Cancer Journal(2024)10.1038/s41408-024-01172-x

N/A

0DataRank · unranked

33 citations

Fumou Sun, Daisy Alapat, Visanu Wanchai, David E. Mery, Eric R. Siegel +15 more

Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency

Journal of Clinical Investigation(2024)10.1172/jci175199

N/A

0DataRank · unranked

20 citations

Orsi Giricz, David T. Melnekoff, R. Alejandro Sica, Veronika Polishchuk, Cristian Papazoglu +22 more

Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems

Blood Cancer Journal(2024)10.1038/s41408-024-00998-9

N/A

0DataRank · unranked

7 citations

Yihao Zhan, David E. Mery, Eric R. Siegel, Fumou Sun, Yan Cheng +14 more

Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition

Experimental Hematology and Oncology(2025)10.1186/s40164-025-00699-4

N/A

0DataRank · unranked

2 citations

Aric Anloague, Japneet Kaur, Cecile Bustamante-Gomez, Sharmin Khan, Bethany C. Paxton +18 more

How Does Age at Diagnosis Influence Multiple Myeloma Survival? Empirical Evidence

Healthcare(2025)10.3390/healthcare13202637

N/A

0DataRank · unranked

1 citations

Ernest Griffin, Daniel Berleant, Phillip Farmer, Ragen Hodge, Carolina Schinke +3 more

The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study

Haematologica(2025)10.3324/haematol.2025.287760

N/A

0DataRank · unranked

0 citations

Phillip Farmer, Joseph Su, Mario Schootman, Chenghui Li, Frits van Rhee +6 more

BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions

Journal of Clinical Investigation(2023)10.1172/jci171396

N/A

0DataRank · unranked

7 citations

Yan Cheng, Jin‐Ran Chen, Visanu Wanchai, David E. Mery, Hongwei Xu +10 more